Related Experiment Video
Updated: Nov 1, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Psoriasis and coronary heart disease-not as severe as predicted
1Department of Cardiology, Galilee Medical Center, 1 Ben Tzvi Blvd., Nahariya 2210001, Israel.
Insights
Psoriasis patients showed less severe coronary artery disease (CAD) than those without psoriasis, despite psoriasis being a potential cardiovascular disease (CVD) risk factor. Anti-inflammatory treatments did not explain this finding.
Area of Science:
- Cardiology
- Dermatology
- Systemic Inflammatory Diseases
Background:
- Psoriasis is a systemic inflammatory condition linked to cardiovascular disease (CVD).
- The precise impact of psoriasis on coronary artery disease (CAD) severity remains incompletely understood.
- This study investigates the relationship between psoriasis and CAD severity.
Purpose of the Study:
- To determine the correlation between psoriasis and the severity of coronary artery disease (CAD).
- To compare CAD severity in patients with and without psoriasis, matched for key cardiovascular risk factors.
Main Methods:
- Retrospective case-control study involving 59 patients with psoriasis and 59 matched controls.
- Coronary angiography data was analyzed.
- CAD severity was assessed by the number and location of affected coronary vessels.
Main Results:
- CAD severity was significantly lower in patients with psoriasis compared to the control group (P=0.038).
- A higher proportion of psoriasis patients had mild or no CAD (62.7%) versus severe CAD (37.3%).
- Conversely, the majority of non-psoriasis patients (57.6%) exhibited severe CAD.
Conclusions:
- Psoriasis patients demonstrated less severe coronary artery disease than the general population.
- The observed difference in CAD severity was not explained by the use of anti-inflammatory medications.
- Psoriasis may be a risk factor for CAD, but its clinical manifestation in the coronary arteries appears less aggressive in affected individuals.
Background:
Psoriasis is a systemic disorder involved in several disease processes, including cancer, metabolic syndrome and cardiovascular disease (CVD). Previous studies showed that psoriasis is most likely an independent risk factor for CVD, yet the extent of its impact on CVD and the extent of coronary artery disease (CAD) remains unclear. We investigated the correlation of psoriasis to the severity of CAD in age and gender-matched patients with CAD with and without psoriasis.
Methods:
This is a retrospective, case-control study of 59 patients with psoriasis who underwent coronary angiography were matched using a computer software to 59 patients without psoriasis according to age, gender, smoking status, hyperlipidemia, hypertension and diabetes. CAD severity was defined according to number of affected vessels (single vs. multiple) and location of lesions (proximal vs. distal).
Results:
CAD severity was significantly higher in the control group compared to the psoriasis group (P = 0.038). Among patients with psoriasis, 20.3% were disease free or with low severity (42.4%), while only 37.3% had severe CAD. Among patients without psoriasis, the majority had severe CAD (57.6%), followed by low severity (30.5%) or disease free (11.9%). We did not find an association of prior treatment with anti-inflammatory medications and the severity of CAD.
Conclusions:
Our results show that although psoriasis may be a risk factor for CAD, psoriatic patients have a less severe CAD compared to the general population. The use of anti-inflammatory medications does not explain this finding.
More Related Videos
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease IV: Preventive Measures

